LQDA250117P7500
- 0.05
- 0.000.00%
Liquidia Newsroom
Breaking Down Liquidia: 4 Analysts Share Their Views
Liquidia Analyst Ratings
Needham Maintains Liquidia(LQDA.US) With Buy Rating, Maintains Target Price $19
Liquidia Technologies: Buy Rating Driven by Yutrepia's FDA Approval Potential and Market Expansion
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
Jim Cramer's Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know
10 Health Care Stocks With Whale Alerts In Today's Session
Analysts Are Bullish on Top Healthcare Stocks: Surgery Partners (SGRY), Liquidia Technologies (LQDA)
BTIG Maintains Liquidia(LQDA.US) With Buy Rating, Raises Target Price to $29
Great Week for Liquidia Corporation (NASDAQ:LQDA) Institutional Investors After Losing 4.5% Over the Previous Year
Wells Fargo Initiates Liquidia(LQDA.US) With Buy Rating, Announces Target Price $20
Express News | Liquidia Corp : Btig Raises Target Price to $29 From $25
Wells Fargo Initiates Coverage on Liquidia With Overweight Rating, $20 Price Target
Here's Arquitos Capital Management's Updates on Liquidia (LQDA)
Watching Liquidia; Hunterbrook Issues Report On Co Titled "FDA Heads to Court to Defend Unprecedented Decision Protecting Lung Drug Monopoly From Liquidia Competition"
Liquidia Insider Buyers See Boost After Market Cap Rose US$107m
Wall Street Analysts See a 126.13% Upside in Liquidia Technologies (LQDA): Can the Stock Really Move This High?
Liquidia Third Quarter 2024 Earnings: Beats Expectations
HC Wainwright & Co. Reiterates Buy on Liquidia, Maintains $29 Price Target
The Analyst Landscape: 11 Takes On Liquidia